Jung Gil Park

2.0k total citations
56 papers, 811 citations indexed

About

Jung Gil Park is a scholar working on Epidemiology, Hepatology and Cancer Research. According to data from OpenAlex, Jung Gil Park has authored 56 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 22 papers in Hepatology and 10 papers in Cancer Research. Recurrent topics in Jung Gil Park's work include Liver Disease Diagnosis and Treatment (28 papers), Liver Disease and Transplantation (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Jung Gil Park is often cited by papers focused on Liver Disease Diagnosis and Treatment (28 papers), Liver Disease and Transplantation (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (7 papers). Jung Gil Park collaborates with scholars based in South Korea, United States and Japan. Jung Gil Park's co-authors include Soo Young Park, Min Kyu Kang, Won Young Tak, Yu Rim Lee, Young Oh Kweon, Se Young Jang, Keun Hur, Hye Won Lee, Young Seok Han and Gyeonghwa Kim and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Jung Gil Park

51 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung Gil Park South Korea 16 341 333 292 188 72 56 811
Se Young Jang South Korea 17 486 1.4× 437 1.3× 272 0.9× 199 1.1× 86 1.2× 58 908
Andrew Dellinger United States 12 349 1.0× 117 0.4× 490 1.7× 168 0.9× 71 1.0× 27 935
Hongqin Xu China 18 194 0.6× 120 0.4× 510 1.7× 338 1.8× 89 1.2× 46 885
Danting Shen China 8 423 1.2× 209 0.6× 326 1.1× 289 1.5× 65 0.9× 10 1.1k
Hyun Chin Cho South Korea 14 336 1.0× 303 0.9× 381 1.3× 350 1.9× 90 1.3× 34 884
Xianxian Zhao China 11 349 1.0× 94 0.3× 140 0.5× 54 0.3× 65 0.9× 18 683
Yongqiang Li China 14 254 0.7× 160 0.5× 144 0.5× 101 0.5× 110 1.5× 67 786
Osamu Maehara Japan 13 196 0.6× 120 0.4× 248 0.8× 266 1.4× 46 0.6× 30 564
Huijie Jiang China 13 204 0.6× 133 0.4× 73 0.3× 132 0.7× 65 0.9× 60 636
Qifan Zhang China 14 316 0.9× 182 0.5× 103 0.4× 157 0.8× 100 1.4× 44 733

Countries citing papers authored by Jung Gil Park

Since Specialization
Citations

This map shows the geographic impact of Jung Gil Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung Gil Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung Gil Park more than expected).

Fields of papers citing papers by Jung Gil Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung Gil Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung Gil Park. The network helps show where Jung Gil Park may publish in the future.

Co-authorship network of co-authors of Jung Gil Park

This figure shows the co-authorship network connecting the top 25 collaborators of Jung Gil Park. A scholar is included among the top collaborators of Jung Gil Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung Gil Park. Jung Gil Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Min Kyu, Jeong Eun Song, Rohit Loomba, et al.. (2024). Comparative associations of MASLD and MAFLD with the presence and severity of coronary artery calcification. Scientific Reports. 14(1). 22917–22917. 7 indexed citations
3.
Kang, Min Kyu, Yu Rim Lee, Sang Soo Lee, et al.. (2024). Diagnostic performance of procalcitonin for bacterial infection in severe alcoholic hepatitis compared with C-reactive protein. BMC Gastroenterology. 24(1). 428–428. 1 indexed citations
4.
Kang, Min Kyu, Gyeonghwa Kim, Jung Gil Park, et al.. (2023). Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma. Genes. 14(10). 1963–1963. 8 indexed citations
5.
Kim, Young-Gon, Kyungsang Kim, Dufan Wu, et al.. (2022). Deep Learning-Based Four-Region Lung Segmentation in Chest Radiography for COVID-19 Diagnosis. Diagnostics. 12(1). 101–101. 15 indexed citations
6.
Woo, Hyun Young, Jeong Heo, Won Young Tak, et al.. (2022). Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial. PLoS ONE. 17(7). e0270716–e0270716. 2 indexed citations
7.
Zhong, Aoxiao, Xiang Li, Dufan Wu, et al.. (2021). Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19. Medical Image Analysis. 70. 101993–101993. 51 indexed citations
8.
Hwang, Jae Seok, Woo Jin Chung, Heon Ju Lee, et al.. (2021). Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites. PLoS ONE. 16(6). e0253886–e0253886.
9.
Kim, Gyeonghwa, Soo Young Park, Won Young Tak, et al.. (2021). Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma. Scientific Reports. 11(1). 14930–14930. 7 indexed citations
10.
Park, Jung Gil, Gyeonghwa Kim, Se Young Jang, et al.. (2020). Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis. Life. 10(10). 230–230. 15 indexed citations
11.
Han, Man‐Hoon, Jee Hyun Lee, Gyeonghwa Kim, et al.. (2020). Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. Genes. 11(5). 545–545. 35 indexed citations
12.
Kang, Min Kyu, Kyeong Ok Kim, Min Cheol Kim, et al.. (2020). Clinical characteristics of coronavirus disease 2019 patients with diarrhea in Daegu. The Korean Journal of Internal Medicine. 35(6). 1261–1269. 10 indexed citations
13.
Lee, Yu Rim, Min Kyu Kang, Jeong Eun Song, et al.. (2020). Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea. Clinical and Molecular Hepatology. 26(4). 562–576. 24 indexed citations
14.
Kang, Min Kyu, Jung Gil Park, & Heon Ju Lee. (2018). Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma. Medicine. 97(17). e0611–e0611. 10 indexed citations
15.
Lee, Yu Rim, Gyeonghwa Kim, Won Young Tak, et al.. (2018). Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma. International Journal of Cancer. 144(6). 1444–1452. 215 indexed citations
16.
Park, Jung Gil, Yu Rim Lee, Soo Young Park, et al.. (2017). Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B. Digestive and Liver Disease. 50(2). 163–167. 5 indexed citations
17.
Lian, Sen, Jung Gil Park, Thi Phuong Nguyen, et al.. (2016). MicroRNA-375 Functions as a Tumor-Suppressor Gene in Gastric Cancer by Targeting Recepteur d’Origine Nantais. International Journal of Molecular Sciences. 17(10). 1633–1633. 22 indexed citations
18.
Park, Jung Gil. (2015). Severe fever with thrombocytopenia syndrome presenting as acute hepatic failure. Clinical and Experimental Emergency Medicine. 2(2). 137–140.
19.
Park, Jung Gil, et al.. (2011). Improvement in Left Ventricular Systolic Dyssynchrony in Hypertensive Patients After Treatment of Hypertension. Korean Circulation Journal. 41(1). 16–16. 2 indexed citations
20.
Yong, Chul Soon, Jung Gil Park, Jung‐Ae Kim, et al.. (2006). Trials of novel13C-urea-containing capsule for more economic and sensitive diagnosis ofHelicobacter pylori infection in human subjects. Archives of Pharmacal Research. 29(10). 879–883. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026